Answers are grounded in this paper and cite their sources.
Nanomaterials in drug delivery systems are emerging as a potential source of treatments. The bioavailability of nano-carriers depends upon various factors including their mode of administration, target specificity, availability of active compound and compatibility with biological system.
No takes yet. Share an insight, caveat, or question.
Prakash et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: